Author

Esther Ortiz

Observed name: Ortiz, Esther

Institution: Esteve (Spain)

Observed institution: Esteve (Spain)

ORCID: 0000-0001-7271-1141

Observed ORCID: 0000-0001-7271-1141

OpenAlex ID: A5048835310

Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: A phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial

2022 · Eugene R. Viscusi, Oscar de Leon‐Casasola, et al. · Pain Practice · 25

Efficacy and safety of co‐crystal of tramadol‐celecoxib ( CTC ) in acute moderate‐to‐severe pain after abdominal hysterectomy: A randomized, double‐blind, phase 3 trial ( STARDOM2 )

2022 · Richard Langford, Adelaida Morte, et al. · European Journal of Pain · 19

Co-crystal of tramadol–celecoxib (CTC) for acute moderate-to-severe pain

2024 · Richard Langford, Cesar Margarit, et al. · Current Medical Research and Opinion · 18

Co-crystal of Tramadol-Celecoxib Versus Tramadol or Placebo for Acute Moderate-to-Severe Pain After Oral Surgery: Randomized, Double-Blind, Phase 3 Trial (STARDOM1)

2024 · Richard Langford, Esther M. Pogatzki-Zahn, et al. · Advances in Therapy · 12

Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: Secondary analyses by baseline pain intensity and use of rescue medication of a phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial

2024 · Eugene R. Viscusi, Oscar de Leon‐Casasola, et al. · Pain Practice · 4

Clinical trial design in gene therapy for neurodegenerative diseases: Sanfilippo A syndrome

2020 · Adelaida Morte, Mariano Sust, et al. · Cell and Gene Therapy Insights

Works count: 7

Citation count: 78

H-index: 4

I10-index: 4